NICE

Summary: Voxelotor is the first medicine in Britain to directly inhibit sickle haemoglobin polymerisation Global Blood Therapeutics (GBT) has announced that the…

Summary : Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes National Institute for Health…

Synopsis – England’s National Institute for Health and Care Excellence (NICE) has given a thumbs up to Sobi’s paroxysmal nocturnal hemoglobinuria (PNH)…

  Key Points –   SMC approved Combination of Opdivo (Nivolumab) plus  Cabometryx (Cabozantinib) for treatment of Advanced Renal Carcinoma  In a Phase III…